that mycophenolate-containing medications may interfere with hormonal contraceptive efficacy. Since IUDs are the most effective contraceptive options, we strongly recommend the IUD (copper or progestin) for women with RMD who are receiving immunosuppressive therapy, despite hypothetical infection risk. IUD-associated infection risk in RMD patients receiving immunosuppressive therapy has not been specifically studied, but studies in women with HIV show no increase In women with RMD who are at